Reuters Blogs

DealZone

Behind the deals and deal-makers

14:58 August 18th, 2008

Drug store shopping

Posted by: Phil Wahba
Tags: DealZone

Longs Drug Stores Corp recommended that its shareholders accept a $2.54 billion, or $71.50 per share, takeover offer from CVS Caremark Corp after holding unsuccessful merger talks with Walgreen Co.

In an SEC filing, Longs said it had held talks with an unnamed suitor that had offered $70 per share, but negotiations faltered over concerns about antitrust hurdles. A source familiar with the situation said that suitor had been Walgreen.

Despite the recent articles in the press about the dearth of tech IPOs, PEHub says it has nothing to do with tech itself, or the usual culprits of onerous regulation and the difficulty of getting analyst coverage. Instead, tech IPOs are just suffering along with everyone else amid the IPO market worst slowdown in years.

The New York Times’ Deal Book wonders why the potential acquirers in hostile tech takeovers seem to pursue their quarry so half heartedly, pointing to Electronic Arts allowing its tender offer for Take Two Interactive expire tonight, and Microsoft’s “wishy washy” pursuit of Yahoo.

OTHER DEALS OF THE DAY:

** Brinker International Inc said it agreed to sell a majority interest in restaurant chain Romano’s Macaroni Grill to an affiliate of private equity firm Golden Gate Capital for $131.5 million in cash.

** Mahindra & Mahindra Ltd India’s top tractor maker, said it would take a 51 percent stake in a joint venture with a Chinese firm and the venture would acquire the latter’s tractor operations for $50 million.

** BASF put more of its plastics business up for sale as the world’s biggest chemicals group faces a looming petrochemicals supply glut in the Middle East and rising feedstock prices.

Post Your Comment

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word

House Rules:
  • We moderate all comments and will publish everything that advances the post directly or with relevant tangential information
  • We try not to publish comments that we think are offensive or appear to pass you off as another person, and we will be conservative if comments may be considered libelous information.